Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
International Journal of Cancer|July 15, 1990
Presence of HPV 16 sequences in laryngeal carcinomasM Pérez-Ayala, F Ruiz-Cabello, F Esteban, et al.International Journal of Clinical & Laboratory Research|October 24, 2000
Beta2-microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumorsM A Fernández, F Ruiz-Cabello, M R Oliva, et al.Tissue Antigens|May 1, 1996
Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell lineM J Torres, F Ruiz-Cabello, A Skoudy, et al.Journal of Immunogenetics|August 1, 1989
MHC class I and II antigens on gastric carcinomas and autologous mucosaA Ferron, M Perez-Ayala, A Concha, et al.The Journal of Surgical Research|September 1, 1996
Interleukin-1beta and ibuprofen effects on CD4/CD8 cells after endotoxic challengeA Mansilla-Roselló, J A Ferrón-Orihuela, F Ruiz-Cabello, et al.International Journal of Cancer|August 17, 1999
Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumorsP Jiménez, J Cantón, A Collado, et al.Cancer Immunology, Immunotherapy : CII|October 13, 1998
Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell lineE Abril, L M Real, A Serrano, et al.International Journal of Cancer|February 14, 1998
In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-I alleleL M Real, P Jimenez, J Cantón, et al.Immunobiology|September 1, 1992
HLA molecules in basal cell carcinoma of the skinT Cabrera, V Garrido, A Concha, et al.Immunology Today|February 1, 1997
Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursF Garrido, F Ruiz-Cabello, T Cabrera, et al.Pageof 9